Developing new orphan therapies, increasing access to existing life-saving treatments, and lowering costs is a moral imperative. However, major challenges remain for the rare disease community to achieve these goals.
Industry Leaders Outline Five Important Elements Impacting Rare Disease Drug Development
Published on :BioBuzz Panel on Drug Development in Rare Diseases with regional leaders from AstraZeneca, REGENXBIO, American Gene Technologies, GeneDx and Jeeva Informatics
Four Companies Using Big Data to Drive Innovation in Precision Medicine: A Recap of the 1st Digital Omics Innovators Meetup
Published on :Four Companies Using Big Data to Drive Innovation in Precision Medicine A Recap of the 1st Digital Omics Innovators Meetup By: Joelle Herman, Founder of NeoTrials, LLC An Executive Forum [….]
Summer internship program in precision medicine creates a win-win for students and local company
Published on :Summer Internship Program in Precision Medicine Creates a Win-Win for Students and Local Company Jeeva Informatics, George Mason University and United National Diversity Coalition of America collaborate on successful internship [….]